Cellatoz Therapeutics is a biotech company that specializes in regenerative medicine advanced therapy (RMAT). It aims to develop cell therapies for the treatment of intractable diseases and serious medical conditions, including spinal cord injuries, severe complex fractures, etc. The company uses musculoskeletal stem cell (MSSC) technology enabling the differentiation from embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) into the cells of mesodermal lineage tissues through modulating extracellular microenvironments of MSSC.